Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...
Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion ...
Investigators sought to determine whether abemaciclib plus letrozole showed clinically meaningful activity in patients with advanced or recurrent endometrioid endometrial cancer.
Are you someone who silences every notification the moment it appears, or do you pause and tell yourself: *“Ki ete sa?”* Now ...
The cancer antigen therapy mRNA-4359 yielded a high rate of antitumor responses in combination with pembrolizumab (Keytruda) ...
Learn how G-CSF and trilaciclib help prevent febrile neutropenia in extensive-stage SCLC, with NCCN-backed timing tips and ...
New research suggests hair loss may hinge on a fragile cellular balance during regeneration, where stem cells must survive a ...
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the ...
An octopus-shaped nanomachine hijacks tumor ATP leakage to power a self-amplifying cycle of membrane damage, drug delivery, and metabolic collapse in cancer cells.
Systemic inflammation research occupies a pivotal position at the intersection of immunology, metabolism, and disease pathogenesis. Recent advances have ...
Is A Reversible, Hormone-Free Male Contraceptive Finally Within Reach? In A Nutshell Scientists used a drug in mice to ...
Morning Overview on MSN
E-bike maker plans semi-solid-state battery models, aiming for longer range
Most e-bike batteries on the market today use conventional lithium-ion cells that deliver somewhere between 40 and 80 miles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results